N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements

Blood

Volumn 96, Issue 1, 2000, Pages 203-209

  Noordzij, Jeroen G ^b   Verkaik, Nicole S ^b   Hartwig, Nico G ^b   De Groot, Ronald ^b   Van Gent, Dik C ^b   Van Dongen, Jacques J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; T LYMPHOCYTE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CASE REPORT; COMBINED IMMUNODEFICIENCY; DNA CLEAVAGE; FEMALE; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN STRUCTURE; NEWBORN; PRIORITY JOURNAL; STOP CODON; TRANSLATION INITIATION;

EID: 0034234671     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.203.013k33_203_209     Document Type: Article

References (46)

1. Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular and genetic approach. New York: Oxford University Press; 1999.
2. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147.
3. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130:378.
4. Schwarz K, Gauss GH, Ludwig L, et al. RAG mutations in human B cell-negative SCID. Science. 1996;274:97.
5. Ramsden DA, van Gent DC, Gellert M. Specificity in V(D)J recombination: new lessons from biochemistry and genetics. Curr Opin Immunol. 1997;9:114.
6. van Gent DC, Ramsden DA, Gellert M. The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination. Cell. 1996;85: 107.
7. McBlane JF, van Gent DC, Ramsden DA, et al. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell. 1995;83:387.
8. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869.
9. Shinkai Y, Rathbun G, Lam KP, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992; 68:855.
10. H2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable β repertoire. J Allergy Clin Immunol. 1998;101:131.
11. Appleton AL, Curtis A, Wilkes J, Cant AJ. Differentiation of materno-fetal GVHD from Omenn's syndrome in pre-BMT patients with severe combined immunodeficiency. Bone Marrow Transplant. 1994;14:157.
12. Schandene L, Ferster A, Mascart - Lemone F, et al. T helper type 2-like cells and therapeutic effects of interteron-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol. 1993;23:56.
13. Chilosi M, Facchetti F, Notarangelo LD, et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol. 1996;26:329.
14. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998;93:885
15. Notarangelo LD, Villa A, Schwarz K. RAG and RAG defects Curr Opin Immunol. 1999;11:435.
16. Kirch SA, Sudarsanam P, Oettinger MA. Regions of RAG1 protein critical for V(D)J recombination. Eur J Immunol. 1996;26:886.
17. Kirch SA, Rathbun GA, Oettinger MA. Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly. EMBO J. 1998;17:4881.
18. Sadofsky MJ, Hesse JE, van Gent DC, Gellert M. RAG-1 mutations that affect the target specificity of V(D)J recombination: a possible direct role of RAG-1 in site recognition, Genes Dev. 1995;9: 2193.
19. Steen SB, Han JO, Mundy C, Oettinger MA, Roth DB. Roles of the "dispensable" portions of RAG-1 and RAG-2 in V(D)J recombination. Mol Cell Biol. 1999;19:3010.
20. McMahan CJ, Difilippantonio MJ, Rao N, Spanopoulou E, Schatz DG. A basic motif in the N-terminal region of RAG1 enhances V(D)J recombination activity Mol Cell Biol. 1997;17:4544.
21. -/- B cells reveals a requirement for novel elements in the N-terminus of RAG-1. Immunity. 1997;7:13.
22. Sadolsky MJ, Hesse JE, McBlane JF, Gellert M. Expression and V(D)J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res. 1993;21:5644.
23. Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035.
24. Groeneveld K, van den Beemd R, van Dongen JJM. Immunophenotyping of B cell malignancies. In: Lefkovits I, ed. Immunology Methods Manual, 4. London: Academic Press; 1997:1849.
25. Lucio P, Parreira A, van den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 1999;13:419.
26. Koning H. Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. T cells subsets and cytokines in allergic and non-allergic children, II: analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine. 1997;9:427.
27. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. T cell subsets and cytokines in allergic and non-allergic children, I: analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine. 1997;9:416.
28. Verhagen OJHM, Wijkhuis AJM, van der Sluijs-Gelling AJ, et al. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia. 1999;13:1298.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156.
30. Langerak AW, Dirks RPH, Versnel MA. Splicing of the platelet-derived growth factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression. Eur J Biochem. 1992; 208:589.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press: 1989.
32. Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero ILM, van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia. 1997;11:2192.
33. Szczepanski T, Pongers - Willemse MJ. Langerak AW, et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood. 1999;93:4079.
34. Beishuizen A, de Bruijn MA, Pongers - Willemse MJ, et al. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia. 1997;11:2200.
35. Pongers - Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 Concerted Action investigation of minimal residual disease in acute leukemia Leukemia. 1999;13: 110.
36. Breit TM, Van Dongen JJM Unravelling human T-cell receptor junctional region sequences Thymus. 1994;22:177.
37. Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families. Immunogenetics. 1995;42:455.
38. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 1999;27:209.
39. Van Dongen JJM, Van den Beemd MWM, Schellekens M, Wolvers - Tettero ILM, Langerak AW, Groeneveld K. Analysis of malignant T cells with the Vβ antibody panel. Immunologist. 1996; 4:37.
40. Signorini S, Imberti L, Pirovano S, et al. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood. 1999;94:3468.
41. Brooks EG, Filipovich AH, Padgett JW, Mamlock R, Goldblum RM. T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. Blood. 1999;93: 242.
42. Akira S, Okazaki K, Sakano H. Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining. Science. 1987;238: 1134
43. Hesse JE, Lieber MR, Mizuuchi K, Gellert M. V(D)J recombination: a functional definition of the joining signals. Genes Dev. 1989;3:1053.
44. Szczepanski T, Beishuizen A, Pongers - Willemse MJ, et al. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia. 1999;13: 196.
45. Van Dongen JJM, Wolvers - Tettero ILM. Analysis of immunoglobulin and T cell receptor genes, II: possibilities and limitations in the diagnosis of lymphoproliferative diseases and related disorders. Clinic Chim Acta. 1991;198:93.
46. Van den Beemd MWM, Boor PPC, Van Lochem EG, et al. Flow cytometric analysis of the Vβ repertoire in healthy controls. Cytometry. In press.